Q2 2025 Lifco AB (publ) Earnings Call Transcript

Jul 14, 2025 / 07:00AM GMT
Release Date Price: $19.42

Key Points

Positve
  • Lifco AB (LFABF) reported a 3% sales growth in Q2 2025, with a slight positive organic growth of 0.5%.
  • The company achieved a 7% growth from acquisitions during the quarter.
  • For the first six months of 2025, Lifco AB (LFABF) experienced a 9% sales growth and a 6% EBITA growth.
  • The Demolition and Tools segment showed signs of stabilization with a 5.5% sales growth and 13.7% EBITA growth over the first six months.
  • Lifco AB (LFABF) maintains a solid financial position with a stable net debt to EBITDA ratio of 1.3 times, allowing for continued acquisitions in niche companies.
Negative
  • The EBITA margin declined from 23.9% in the previous year to 22.5% in Q2 2025 due to a negative product mix effect.
  • Cash flow declined by 8.5%, partly due to a small decline in EBITA and a working capital build-up in the contract manufacturing subdivision.
  • The Dental segment experienced a 2% sales decline and a 5% EBITA decline in Q2 2025, impacted by a later Easter and negative foreign exchange effects.
  • Systems Solutions saw weaker development with a significant drop in growth rates from 95% in Q1 to 17% in Q2 2025.
  • There was a general slowdown in market conditions, particularly in environmental products, transportation products, and special products, leading to lower customer investment decisions.
Operator

Welcome to Lifco Q2 report for 2025. (Operator Instructions)

Now I will hand the conference over to CEO, Per Waldemarson; and CFO, Therese Hoffman. Please go ahead.

Per Waldemarson;publ;President
Lifco AB;Chief Executive Officer, Director

()- -

Thank you, and good morning, and welcome to everyone. We can start with page number 2 in our investor presentation and take a look at the overall numbers for the Lifco Group. And if we start with the second quarter on the sales line, it was a softer quarter where some segments faced more difficult market conditions. We will come back to that shortly.

Overall, the sales growth with roughly 3% with a slight positive organic growth around 0.5%. We had negative effects from the foreign exchange rates of 4.4% and around 7% growth from acquisition in the quarter. In the quarter, Dental had somewhat negative effect in the second quarter from later Easter this year compared to previous year.

Overall, if we go further down and look at profit and margins, we can

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot